Company & Industry News
By Rich Quelch, Global Head of Marketing, Origin Pharmaceutical packaging is an industry going from strength to strength and its shows no signs of slowing down. In fact, by 2025 the market is expected to be worth $128 billion. The main drivers of this growth are: increased global demand for medication from emerging economies; an ageing…
By Rich Quelch, Global Head of Marketing, Origin Antimicrobial resistance (AMR) is a complex and global issue, affecting all regions of the world. If current trends continue, it’s believed by 2050 antibiotic resistance will cause more deaths per year than cancer, becoming the world’s biggest killer. As such, AMR is currently high on the political…
It’s very easy to go about your day to day life without thinking about the impact the products you buy and use have on the environment. Although there has been a surge in interest in single-use plastics, the reality is that many of us aren’t aware of the damage we’re doing to the planet. Every…
GSK, Bristol-Myers Squibb, Novartis and AstraZeneca to name but a few are investing billions of dollars in biologics to have prime mover advantage in a market forecast to be worth nearly $480 billion by 2024. It’s clear biologics are the future of medicine based on their proven ability to treat major chronic diseases better than…
As legislation and ethical awareness evolves, Origin Pharma Packaging has seen the demand for innovative design and production of child safe packaging increase on a global scale. Our new product development (NPD) team are continually investing their time and knowledge developing commercial solutions for child resistant compliant packaging for the UK, Europe, the U.S.A and…
Meeting in Nairobi in December 2017, the United Nations Environment Assembly committed to a new resolution, urging all countries, ‘to prevent and significantly reduce marine pollution of all kinds, in particular from land-based activities’ by 2025. It claims, unless we take action, our oceans will contain more plastic than fish by 2050. The call to…
Pharmaceuticals companies are experiencing a wave of competing challenges as part of what PwC refers to as the New Health Economy. These include market consolidation for efficiency gains; the changing demands and needs of patients and increasing cost pressures from payors leading to calls for pricing reform. Jon Lant, Head of New Product Development & Innovation,…
We hope you enjoyed the conference at Pharma Security World 2019. Welcome to the brand new PharmiTrack & CliniWatch Presentation powered by our patented Perennial Encrypted Technology, Smart-i. You have been digitally transported to this page for the first installment from the Smart-i hand out, however if you are visiting our blog for the first…
Technology is advancing and evolving with every passing day. This is certainly true in the health industry, and it is incredible to think just how far we have come. These days, it’s not uncommon to have robotics as an element during surgeries while virtual reality tech is being used in medical schools to give students…